While ITGB1 and CD47 are implicated in hepatocellular carcinoma, therapeutic efficacy in HCC models was not evaluated here and will require future validation in hepatocyte-derived and in vivo systems. Here, ITGB1 is linked to hepatocellular carcinoma.